EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Linear IgA bullous dermatosis: 32 years of experience

Tugba Atci, Gizem Pehlivan Ulutas, Ecem Güreler Sirkeci, Rıfkiye Küçükoğlu

Anais Brasileiros de Dermatologia · 2025

DOI: 10.1016/j.abd.2024.03.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anais Brasileiros de Dermatologia, 2025. Verfasst von Tugba Atci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. Electronic address: tugba.ertan@istanbul.…. Hauptthemen laut MEDLINE: Linear IgA Bullous Dermatosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Linear IgA bullous dermatosis (LABD) is an uncommon disease with only a few reported studies in large series with long follow-up periods.

Objectives

To evaluate the clinical presentation, immunopathological features, management, and disease course in LABD patients.

Methods

Data including demographics, clinical features, histopathological and immunofluorescence findings of LABD patients, in addition to the preferred treatments and responses to treatments were evaluated.

Results

Among 26 patients diagnosed with LABD, 17 (65.4%) were female. The mean age was 40.3 ± 22.4 (6-80) years of whom 21 were adults. The most common mucosal involvement was oral (n = 9, 34.6%). Continuous linear IgA deposition was present on the basement membrane zone of all patients in addition to C3 (n = 13), IgG (n = 9), IgM (n = 4), and fibrinogen (n = 4). Three patients were lost to follow-up without any treatment. Dapsone was the treatment of choice in most (n = 21, 91.3%) patients in addition to systemic corticosteroids (n = 17), azathioprine (n = 3), tetracycline and nicotinamide (n = 2). Complete and partial remissions were achieved in 11 (47.8%) and 12 (52.2%) patients, respectively, in a mean follow-up period of 45.9 ± 43.9 (3-158) months. Furthermore, 17 patients were still under treatment at the end of the follow-up period. Study limitations: Retrospective study conducted in a single center.

Conclusions

LABD may occur at two separate peaks, one in the second and the other in the sixth decade of life with a female predominance. Other immunoglobulins may be associated with dominant IgA antibody deposition and the most commonly used therapeutic option for LABD patients was oral dapsone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Linear IgA Bullous DermatosisHumansFemaleAdultMiddle AgedAgedMaleAged, 80 and overYoung AdultDapsoneAdolescentRetrospective StudiesChildTreatment OutcomeImmunoglobulin A

Stichwörter der Autor:innen

Autoimmune diseasesLinear IgA bullous dermatosisSkin diseasesVesiculobullous

Substanzen

DapsoneImmunoglobulin A

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. Electronic address: tugba.ertan@istanbul.edu.tr.
  • Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Sultangazi Haseki Training and Research Hospital, Istanbul, Turkey.
  • Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Zitieren

APA

Atci, T., Pehlivan Ulutas, G., Güreler Sirkeci, E., & Küçükoğlu, R. (2025). Linear IgA bullous dermatosis: 32 years of experience. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2024.03.015

Vancouver

Atci T, Pehlivan Ulutas G, Güreler Sirkeci E, Küçükoğlu R. Linear IgA bullous dermatosis: 32 years of experience. Anais Brasileiros de Dermatologia. 2025. doi:10.1016/j.abd.2024.03.015

BibTeX
@article{Atci2025,
  author = {Atci, Tugba and Pehlivan Ulutas, Gizem and Güreler Sirkeci, Ecem and Küçükoğlu, Rıfkiye},
  title = {Linear IgA bullous dermatosis: 32 years of experience},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2025},
  doi = {10.1016/j.abd.2024.03.015}
}
Kostenlos starten →